Increased susceptibility of ifn-γ-treated neuroblastoma cells to lysis by lymphokine-activated killer cells: Participation of ICAM-1 induction on target cells

This publication has 18 references indexed in Scilit:

• Involvement of CD56 (NKH-1/Leu-19 antigen) as an adhesion molecule in natural killer-target cell interaction.
  The Journal of Experimental Medicine, 1989
• Complete remission of recurrent glioblastoma multiforme following local infusions of lymphokine activated killer cells
  Acta Neurochirurgica, 1989
• Interferon is able to reduce tumor cell susceptibility to human lymphokine-activated killer (LAK) cells
  Cellular Immunology, 1989
• Adhesion of T lymphoblasts to epidermal keratinocytes is regulated by interferon gamma and is mediated by intercellular adhesion molecule 1 (ICAM-1).
  The Journal of Experimental Medicine, 1988
• Purified intercellular adhesion molecule-1 (ICAM-1) is a ligand for lymphocyte function-associated antigen 1 (LFA-1)
  Cell, 1987
• Application of Interleukin 2 in Neuroblastoma
  Published by Springer Nature ,1987
• Polypeptides on human B lymphocytes associated with cell activation
  Human Immunology, 1986
• Effects of monoclonal antibodies to the a and β chains of the human lymphocyte function‐associated (H‐LFA‐1) antigen on T lymphocyte functions
  European Journal of Immunology, 1985
• Lymphokine-activated killer cell phenomenon. Lysis of natural killer-resistant fresh solid tumor cells by interleukin 2-activated autologous human peripheral blood lymphocytes.
  The Journal of Experimental Medicine, 1982
• Immune aspects of neuroblastoma
  The American Journal of Surgery, 1971